Literature DB >> 33183587

Auxiliary active site mutations enhance the glycosynthase activity of a GH18 chitinase for polymerization of chitooligosaccharides.

Cristina Alsina1, Enea Sancho-Vaello1, Almudena Aranda-Martínez1, Magda Faijes1, Antoni Planas2.   

Abstract

Depolymerization of chitin results in chitooligosaccharides (COS) that induce immunostimulatory effects and disease protective responses and have many potential applications in agriculture and medicine. Isolation of bioactive COS with degree of polymerization (DP) larger than six from chitin hydrolyzates is hampered by their water insolubility. Enzymatic synthesis by exploiting the transglycosylation activity of GH18 chitinases offers a potential strategy to access oligomers in the range of bioactive DPs. We engineered SpChiD chitinase as a glycosynthase by mutation of the assisting residue of the catalytic triad in the substrate-assisted mechanism for polymerization of an oxazoline substrate (DP5ox). The insoluble polymer containing DP10 was partially hydrolyzed due to the significant residual hydrolase activity of the mutant enzyme. Combined mutations that strongly reduce the hydrolytic activity, in which the original catalytic triad only retains the essential acid/base residue, together with neighboring mutations in the -1/+1 subsites region, render glycosynthase-like chitinases able to produce chitin oligomers with DP10 as major product in good yields.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chitin; Chitinase; Chito-oligosaccharides; Glycosynthase; Oxazoline donor; Polymerization; Substrate-assisted catalysis; Synthetic chitin polymers

Mesh:

Substances:

Year:  2020        PMID: 33183587     DOI: 10.1016/j.carbpol.2020.117121

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  1 in total

1.  Optimizing Chitin Depolymerization by Lysozyme to Long-Chain Oligosaccharides.

Authors:  Arnaud Masselin; Antoine Rousseau; Stéphanie Pradeau; Laure Fort; Rodolphe Gueret; Laurine Buon; Sylvie Armand; Sylvain Cottaz; Luc Choisnard; Sébastien Fort
Journal:  Mar Drugs       Date:  2021-05-31       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.